Recognizing the heterogeneity of DLBCL
Update on the clinical management of diffuse large B-cell lymphoma
Christian Gisselbrecht et al.
Negative-data clinical trials in lymphoma presented at ASH 2015
Panel discussion on the treatment of adolescent and young adult lymphoma patients
Catherine Bollard et al.
Upcoming trials for DLBCL: R-CHOP with acalabrutinib and obinutuzumab with checkpoint inhibitor